Patients with eosinophilic gastroenteritis generally respond well to corticosteroids but relapses are common. Patients with relapsing disease are usually placed on long-term low-dose prednisone or immunosuppressive therapy. Here we reported on a patient with severe steroid-dependent eosinophilic gastroenteritis who was able to successfully taper off steroids and maintain remission after starting montelukast, a leukotriene receptor antagonist. To our knowledge, this is the first use of montelukast as a steroid sparing agent for eosinophilic gastroenteritis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1023/a:1010682310928 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!